Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban vs Warfarin for LV Thrombus after AMI
NCT06515730Phase 4Recruiting
- Sponsor
- Karolinska Institutet
- Start
- Apr 2025
- Primary completion
- Apr 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of apixaban in left ventricular thrombus (LVT), sponsored by Karolinska Institutet. Started Apr 2025; status: recruiting.
02
Drugs
apixaban
03
Conditions
left ventricular thrombus (LVT)
Beyond the preview
Go deeper on NCT06515730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06515730.